Umbilical Cord Tissue in Sacral Ulcers
Jan 10, 2023
Abstract Sacral decubitus ulcers—commonly referred to as pressure ulcers—affect thousands of patients each year. Standard care can be costly and… Read More >
Application of Umbilical Cord Tissue Allografts in Reduction Mammoplasty Wound: A Case Study
Dec 12, 2022
Abstract Nearly 15 million cosmetic procedures are performed annually in the U.S., including breast augmentations, lifts, and reductions. One of… Read More >
Advances through Value-Based Outcomes
Nov 30, 2022
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
Application of Amniotic Membrane Allografts in Advanced Venous Leg Ulcer: A Case Study and Literature Review
Sep 07, 2022
Research Article Abstract Chronic Venous Insufficiency (CVI) is a long-term condition that can lead to significant personal and healthcare burdens…. Read More >
Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing
Aug 15, 2022
This includes the analogous nature of articular cartilage, muscle fascia, and intervertebral disc confirmed by way of comparative Scanning Electron… Read More >
Three-Dimensional Electron Microscopy of Human Umbilical Cord Tissue Allograft Pre and Post Processing: A Literature Comparison
Aug 15, 2022
Imaging-Based Evidence for Minimal Manipulation Under FDA’s framework for Section 361 HCT/Ps, minimal manipulation of structural tissue means processing does… Read More >
Regenative Labs Releases New Study To Revolutionize Treatment For Patients With Diabetic Foot Ulcers
Aug 08, 2022
Future applications for the early, preventative use of amniotic membrane allografts in addition to the current standard of care for… Read More >